Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.
JSR Corporation, Tokyo 105-0021, Japan.
World J Gastroenterol. 2023 May 28;29(20):3145-3156. doi: 10.3748/wjg.v29.i20.3145.
Cancer detection is a global research focus, and novel, rapid, and label-free techniques are being developed for routine clinical practice. This has led to the development of new tools and techniques from the bench side to routine clinical practice. In this study, we present a method that uses Raman spectroscopy (RS) to detect cancer in unstained formalin-fixed, resected specimens of the esophagus and stomach. Our method can record a clear Raman-scattered light spectrum in these specimens, confirming that the Raman-scattered light spectrum changes because of the histological differences in the mucosal tissue.
To evaluate the use of Raman-scattered light spectrum for detecting endoscop-ically resected specimens of esophageal squamous cell carcinoma (SCC) and gastric adenocarcinoma (AC).
We created a Raman device that is suitable for observing living tissues, and attempted to acquire Raman-scattered light spectra in endoscopically resected specimens of six esophageal tissues and 12 gastric tissues. We evaluated formalin-fixed tissues using this technique and captured shifts at multiple locations based on feasibility, ranging from six to 19 locations 200 microns apart in the vertical and horizontal directions. Furthermore, a correlation between the obtained Raman scattered light spectra and histopathological diagnosis was performed.
We successfully obtained Raman scattered light spectra from all six esophageal and 12 gastric specimens. After data capture, the tissue specimens were sent for histopathological analysis for further processing because RS is a label-free methodology that does not cause tissue destruction or alterations. Based on data analysis of molecular-level substrates, we established cut-off values for the diagnosis of esophageal SCC and gastric AC. By analyzing specific Raman shifts, we developed an algorithm to identify the range of esophageal SCC and gastric AC with an accuracy close to that of histopathological diagnoses.
Our technique provides qualitative information for real-time morphological diagnosis. However, further evaluations require an excitation light source with low human toxicity and large amounts of data for validation.
癌症检测是全球研究重点,为了常规临床应用,正在开发新颖、快速且无标记的技术。这导致了从实验室到常规临床实践的新工具和技术的发展。在这项研究中,我们提出了一种使用拉曼光谱(RS)检测未经染色的福尔马林固定、切除的食管和胃标本中癌症的方法。我们的方法可以在这些标本中记录清晰的拉曼散射光光谱,证实拉曼散射光光谱因粘膜组织的组织学差异而发生变化。
评估拉曼散射光光谱在检测内镜切除的食管鳞状细胞癌(SCC)和胃腺癌(AC)标本中的应用。
我们创建了一种适合观察活组织的拉曼设备,并尝试在六例食管组织和十二例胃组织的内镜切除标本中获取拉曼散射光光谱。我们使用该技术评估福尔马林固定组织,并根据可行性在多个位置捕捉偏移,范围从六个到 19 个位置,在垂直和水平方向上间隔 200 微米。此外,还对获得的拉曼散射光光谱与组织病理学诊断之间的相关性进行了评估。
我们成功地从所有六例食管和十二例胃标本中获得了拉曼散射光光谱。在数据采集后,由于 RS 是一种不造成组织破坏或改变的无标记方法,因此将组织标本送去进行组织病理学分析以供进一步处理。基于对分子水平底物的数据分析,我们为食管 SCC 和胃 AC 的诊断建立了截止值。通过分析特定的拉曼位移,我们开发了一种算法来识别接近组织病理学诊断的食管 SCC 和胃 AC 的范围。
我们的技术为实时形态学诊断提供了定性信息。然而,进一步的评估需要低人体毒性和大量数据的激发光源进行验证。